Donald Cairns

573 total citations
31 papers, 469 citations indexed

About

Donald Cairns is a scholar working on Pathology and Forensic Medicine, Biochemistry and Molecular Biology. According to data from OpenAlex, Donald Cairns has authored 31 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 11 papers in Biochemistry and 9 papers in Molecular Biology. Recurrent topics in Donald Cairns's work include Biomedical Research and Pathophysiology (11 papers), Amino Acid Enzymes and Metabolism (10 papers) and Neonatal Health and Biochemistry (9 papers). Donald Cairns is often cited by papers focused on Biomedical Research and Pathophysiology (11 papers), Amino Acid Enzymes and Metabolism (10 papers) and Neonatal Health and Biochemistry (9 papers). Donald Cairns collaborates with scholars based in United Kingdom, United States and India. Donald Cairns's co-authors include Graeme Kay, Rachel M. Knott, Kerr H. Matthews, Barbara McKenzie, Ziad Omran, Terence C. Jenkins, Osama Chahrour, Narinder Singh, Navneet Kaur and John F. Callan and has published in prestigious journals such as International Journal of Pharmaceutics, Biochemical Pharmacology and Organic Letters.

In The Last Decade

Donald Cairns

26 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donald Cairns United Kingdom 10 138 88 71 69 69 31 469
Teh‐Min Hu Taiwan 14 114 0.8× 11 0.1× 38 0.5× 28 0.4× 40 0.6× 44 582
Karl A. Schellenberg United States 15 361 2.6× 15 0.2× 197 2.8× 42 0.6× 78 1.1× 26 744
Milena Salerno France 21 400 2.9× 16 0.2× 24 0.3× 13 0.2× 42 0.6× 37 898
Jacques H. Poupaert Belgium 13 267 1.9× 21 0.2× 32 0.5× 62 0.9× 55 0.8× 52 636
Avner Ramu Israel 14 335 2.4× 11 0.1× 8 0.1× 30 0.4× 27 0.4× 24 676
G. Hendriks Netherlands 11 94 0.7× 13 0.1× 9 0.1× 17 0.2× 84 1.2× 13 340
Daniel L. Rathbone United Kingdom 18 242 1.8× 17 0.2× 29 0.4× 12 0.2× 92 1.3× 48 847
Herbert Bartsch Austria 14 225 1.6× 16 0.2× 14 0.2× 17 0.2× 50 0.7× 74 624
Atsuo Miyagishima Japan 16 280 2.0× 72 0.8× 8 0.1× 285 4.1× 55 0.8× 36 777

Countries citing papers authored by Donald Cairns

Since Specialization
Citations

This map shows the geographic impact of Donald Cairns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald Cairns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald Cairns more than expected).

Fields of papers citing papers by Donald Cairns

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald Cairns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald Cairns. The network helps show where Donald Cairns may publish in the future.

Co-authorship network of co-authors of Donald Cairns

This figure shows the co-authorship network connecting the top 25 collaborators of Donald Cairns. A scholar is included among the top collaborators of Donald Cairns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald Cairns. Donald Cairns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cairns, Donald, et al.. (2022). Evaluation of NACA and diNACA in human cystinosis fibroblast cell cultures as potential treatments for cystinosis. Orphanet Journal of Rare Diseases. 17(1). 231–231. 5 indexed citations
2.
McKenzie, Barbara, Graeme Kay, Kerr H. Matthews, Rachel M. Knott, & Donald Cairns. (2016). Preformulation of cysteamine gels for treatment of the ophthalmic complications in cystinosis. International Journal of Pharmaceutics. 515(1-2). 575–582. 21 indexed citations
3.
McKenzie, Barbara, Graeme Kay, Kerr H. Matthews, Rachel M. Knott, & Donald Cairns. (2015). The hen’s egg chorioallantoic membrane (HET-CAM) test to predict the ophthalmic irritation potential of a cysteamine-containing gel: Quantification using Photoshop® and ImageJ. International Journal of Pharmaceutics. 490(1-2). 1–8. 82 indexed citations
4.
Cairns, Donald, et al.. (2013). Three salts from the reactions of cysteamine and cystamine withL-(+)-tartaric acid. Acta Crystallographica Section C Crystal Structure Communications. 69(6). 658–664. 1 indexed citations
5.
Kay, Graeme, et al.. (2012). Suppository formulations as a potential treatment for nephropathic cystinosis. Journal of Pharmaceutical Sciences. 101(10). 3729–3738. 3 indexed citations
6.
Chahrour, Osama, Donald Cairns, & Ziad Omran. (2012). Small Molecule Kinase Inhibitors as Anti-Cancer Therapeutics. Mini-Reviews in Medicinal Chemistry. 12(5). 399–411. 44 indexed citations
7.
Omran, Ziad, et al.. (2011). Synthesis and in vitro evaluation of novel pro-drugs for the treatment of nephropathic cystinosis. Bioorganic & Medicinal Chemistry. 19(11). 3492–3496. 9 indexed citations
8.
Omran, Ziad, et al.. (2011). Folate pro-drug of cystamine as an enhanced treatment for nephropathic cystinosis. Bioorganic & Medicinal Chemistry Letters. 21(8). 2502–2504. 11 indexed citations
9.
Kay, Graeme, et al.. (2010). Gel formulations for treatment of the ophthalmic complications in cystinosis. International Journal of Pharmaceutics. 392(1-2). 192–197. 38 indexed citations
10.
Omran, Ziad, et al.. (2010). PEGylated derivatives of cystamine as enhanced treatments for nephropathic cystinosis. Bioorganic & Medicinal Chemistry Letters. 21(1). 45–47. 9 indexed citations
11.
McCaughan, Bridgeen, Graeme Kay, Rachel M. Knott, & Donald Cairns. (2008). A potential new prodrug for the treatment of cystinosis: Design, synthesis and in-vitro evaluation. Bioorganic & Medicinal Chemistry Letters. 18(5). 1716–1719. 19 indexed citations
12.
Hadizadeh, Fatemeh, et al.. (2003). Poster Session 3 — Medicinal Chemistry. Journal of Pharmacy and Pharmacology. 55(Supplement_1). S–87. 1 indexed citations
13.
Cairns, Donald, et al.. (2003). Modulation of [3H] TBOB binding to the rodent GABAA receptor by simple disaccharides. Biochemical Pharmacology. 65(4). 619–623. 4 indexed citations
14.
Cairns, Donald, Rosaleen J. Anderson, Philip J Perry, & Terence C. Jenkins. (2002). Design of Telomerase Inhibitors for the Treatment of Cancer. Current Pharmaceutical Design. 8(27). 2491–2504. 17 indexed citations
15.
Cairns, Donald. (2000). Essentials of Pharmaceutical Chemistry. Medical Entomology and Zoology. 62 indexed citations
16.
Anderson, Rosaleen J., et al.. (1997). Molecular Modelling of Anthraquinone–Oligodeoxynucleotide Conjugates Containing Protonated Cytosines. Pharmacy and Pharmacology Communications. 3(12). 569–572.
17.
Anderson, R. J., Jeffrey Brown, John A. Hartley, et al.. (1996). Anthraquinone‐oligodeoxynucleotide Conjugates as Triple Helix Stabilizing Agents. Pharmacy and Pharmacology Communications. 2(1). 49–53.
18.
Anderson, R. J., et al.. (1996). Molecular Modelling of Anthraquinone‐oligodeoxynucleotide Conjugates. Pharmacy and Pharmacology Communications. 2(11). 545–548.
19.
Cairns, Donald & John Hay. (1994). Naphthalene Black Staining of Granules of Eosinophilic Granulocytes: Proposed Mechanism of Action Using Chemical Blockade and Computer Graphics. Biotechnic & Histochemistry. 69(3). 157–159. 1 indexed citations
20.
Cairns, Donald. (1990). Staff Development through Quality Circles. The Clearing House A Journal of Educational Strategies Issues and Ideas. 64(2). 87–89.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Teh‐Min Hu Breakdown of academic impact, for papers by Karl A. Schellenberg Breakdown of academic impact, for papers by Milena Salerno Breakdown of academic impact, for papers by Jacques H. Poupaert Breakdown of academic impact, for papers by Avner Ramu Breakdown of academic impact, for papers by G. Hendriks Breakdown of academic impact, for papers by Daniel L. Rathbone Breakdown of academic impact, for papers by Herbert Bartsch Breakdown of academic impact, for papers by Atsuo Miyagishima
Rankless by CCL
2026